Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
Abstract
Despite the “hype” for monoclonal antibodies, the so-called biologics, which added significant value to the therapeutic armamentarium of dermatologists and improved the life of many patients, but may exhibit significant adverse effects, the vast majority of dermatological patients suffering from atopic dermatitis or psoriasis is still treated topically. Thus, there is a huge need for locally applied, locally acting drugs for inflammatory skin...
Paper Details
Title
Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
Published Date
Jul 4, 2019
Journal
Volume
28
Issue
9
Pages
1002 - 1009
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History